Prevest Denpro Ltd (PREVEST) Q4FY25 Concall Summary - Mar-2025 Qtr
Performance Overview
- Prevest Denpro reported 13% revenue growth year-on-year, reaching INR 67.09 crores.
- Domestic sales increased by 13% and export sales by 10% year-on-year.
- The company entered the digital dentistry market with 3D printers and scanners.
- Axiodent Incorporation, a U.S. subsidiary, secured substantial orders and private labeling partnerships.
- Oradox, the oral care product line, is expected to become a key business segment.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.